Evidera
Zaneta Balantac is an accomplished Research Associate III at Evidera, specializing in managing a diverse portfolio of Outcomes Research projects for pharmaceutical, biotech, and medical device companies since April 2014. With a strong background in health outcomes research, Zaneta has led patient-reported and clinician-reported outcome analyses that support regulatory compliance and promotional claims. Prior experience includes roles at United BioSource Corporation, where project management in health outcomes research was emphasized, and impactful service as a Peace Corps Health Volunteer, focusing on public health project development and health systems improvement. Zaneta holds a Bachelor of Science degree in Biology from Brown University.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.